Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 7.47
(-0.53%)
CNY 7.47
(-0.53%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 644.97 Million CNY | 17.37% |
| 2022 | 549.53 Million CNY | -12.74% |
| 2021 | 629.76 Million CNY | 75.8% |
| 2020 | 358.23 Million CNY | -30.57% |
| 2019 | 515.95 Million CNY | -15.06% |
| 2018 | 607.43 Million CNY | -35.3% |
| 2017 | 938.88 Million CNY | -4.07% |
| 2016 | 978.73 Million CNY | 6.19% |
| 2015 | 921.67 Million CNY | 20.39% |
| 2014 | 765.58 Million CNY | 21.88% |
| 2013 | 628.14 Million CNY | 15.31% |
| 2012 | 544.75 Million CNY | 33.3% |
| 2011 | 408.68 Million CNY | 49.95% |
| 2010 | 272.55 Million CNY | 56.16% |
| 2009 | 174.53 Million CNY | 19.12% |
| 2008 | 146.51 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 99.01 Million CNY | -28.16% |
| 2024 Q3 | 120.85 Million CNY | 23.77% |
| 2024 Q1 | 137.83 Million CNY | -5.71% |
| 2023 Q4 | 146.17 Million CNY | -7.04% |
| 2023 Q1 | 162.2 Million CNY | 20.04% |
| 2023 FY | 644.97 Million CNY | 17.37% |
| 2023 Q2 | 179.35 Million CNY | 10.57% |
| 2023 Q3 | 157.23 Million CNY | -12.33% |
| 2022 Q3 | 134.32 Million CNY | 2.75% |
| 2022 FY | 549.53 Million CNY | -12.74% |
| 2022 Q1 | 149.36 Million CNY | -4.65% |
| 2022 Q2 | 130.72 Million CNY | -12.48% |
| 2022 Q4 | 135.12 Million CNY | 0.6% |
| 2021 Q2 | 163.57 Million CNY | 6.8% |
| 2021 Q4 | 156.65 Million CNY | 0.19% |
| 2021 FY | 629.76 Million CNY | 75.8% |
| 2021 Q1 | 153.16 Million CNY | 29.76% |
| 2021 Q3 | 156.36 Million CNY | -4.41% |
| 2020 Q1 | 67.89 Million CNY | -39.13% |
| 2020 FY | 358.23 Million CNY | -30.57% |
| 2020 Q2 | 69.67 Million CNY | 2.62% |
| 2020 Q4 | 118.03 Million CNY | 15.02% |
| 2020 Q3 | 102.62 Million CNY | 47.29% |
| 2019 FY | 515.95 Million CNY | -15.06% |
| 2019 Q4 | 111.53 Million CNY | -20.47% |
| 2019 Q3 | 140.23 Million CNY | 19.53% |
| 2019 Q2 | 117.32 Million CNY | -20.12% |
| 2019 Q1 | 146.86 Million CNY | 32.35% |
| 2018 Q1 | 186.14 Million CNY | -21.22% |
| 2018 FY | 607.43 Million CNY | -35.3% |
| 2018 Q3 | 168.5 Million CNY | 18.81% |
| 2018 Q4 | 110.96 Million CNY | -34.15% |
| 2018 Q2 | 141.82 Million CNY | -23.81% |
| 2017 Q4 | 236.28 Million CNY | -17.31% |
| 2017 Q2 | 196.51 Million CNY | -10.81% |
| 2017 FY | 938.88 Million CNY | -4.07% |
| 2017 Q3 | 285.74 Million CNY | 45.41% |
| 2017 Q1 | 220.33 Million CNY | -12.11% |
| 2016 Q2 | 216.14 Million CNY | -14.83% |
| 2016 Q4 | 250.7 Million CNY | -2.87% |
| 2016 Q1 | 253.77 Million CNY | 18.44% |
| 2016 Q3 | 258.11 Million CNY | 19.42% |
| 2016 FY | 978.73 Million CNY | 6.19% |
| 2015 Q4 | 214.26 Million CNY | -5.56% |
| 2015 Q3 | 226.87 Million CNY | -7.96% |
| 2015 Q2 | 246.49 Million CNY | 5.33% |
| 2015 FY | 921.67 Million CNY | 20.39% |
| 2015 Q1 | 234.03 Million CNY | 30.08% |
| 2014 FY | 765.58 Million CNY | 21.88% |
| 2014 Q4 | 179.91 Million CNY | -12.15% |
| 2014 Q3 | 204.78 Million CNY | 3.1% |
| 2014 Q2 | 198.63 Million CNY | 8.99% |
| 2014 Q1 | 182.24 Million CNY | 13.66% |
| 2013 Q3 | 174.25 Million CNY | 20.36% |
| 2013 Q1 | 148.75 Million CNY | 0.0% |
| 2013 FY | 628.14 Million CNY | 15.31% |
| 2013 Q4 | 160.35 Million CNY | -7.98% |
| 2013 Q2 | 144.77 Million CNY | -2.68% |
| 2012 FY | 544.75 Million CNY | 33.3% |
| 2011 Q4 | 109.39 Million CNY | 0.0% |
| 2011 FY | 408.68 Million CNY | 49.95% |
| 2010 FY | 272.55 Million CNY | 56.16% |
| 2009 FY | 174.53 Million CNY | 19.12% |
| 2008 FY | 146.51 Million CNY | 0.0% |